Yair Barron
About Yair Barron
Yair Barron is a CAR-T Process Engineer II at Bristol Myers Squibb in Seattle, Washington, with over a decade of experience in the biotechnology and pharmaceutical industry.
Current Title and Role
Yair Barron currently holds the title of CAR-T Process Engineer II at Bristol Myers Squibb in Seattle, Washington, United States. In his role, he works on the complex processes involved in CAR-T cell therapies, contributing to the development and manufacturing of advanced therapeutic solutions.
Professional Background and Experience
Yair Barron has accumulated over a decade of experience in the biotechnology and pharmaceutical industry. Prior to his current role, he served as CAR-T Process Engineer I at Bristol Myers Squibb from 2019 to 2021. He also worked as a Manufacturing Associate at Juno Therapeutics, Inc. from 2016 to 2019, focusing on CAR-T cell therapy manufacturing processes. Additionally, he gained experience as a Senior Site Specialist at Amgen Inc. in Bothell, WA, where he was involved in site operations and support.
Education and Academic Credentials
Yair Barron holds two Bachelor's degrees from the University of Washington, studying both Biochemistry and Chemistry from 2012 to 2014. His strong educational background in these fields has equipped him with the knowledge required for his roles in the biotechnology sector. Prior to his university education, he attended Mesa High School, where he achieved his High School Diploma.
Career at Bristol Myers Squibb
Yair Barron joined Bristol Myers Squibb in 2019 as a CAR-T Process Engineer I and was promoted to CAR-T Process Engineer II. His work in developing and refining CAR-T cell therapy processes has been pivotal to the company's therapeutic advancements. He operates out of the Seattle, Washington location, contributing to one of the leading firms in the pharmaceutical industry.
Previous Roles at Juno Therapeutics and Amgen
Before his tenure at Bristol Myers Squibb, Yair Barron worked at Juno Therapeutics, Inc. as a Manufacturing Associate. In this role, he was tasked with critical aspects of CAR-T cell therapy manufacturing. Earlier in his career, he served as a Senior Site Specialist at Amgen Inc., where he was responsible for site operations and support, acquiring valuable skills that he brought forward into his later roles.